Transcription factor AP-2 alpha (AP-2α)

Transcription factor AP-2 alpha (AP-2α) is a sequence-specific DNA-binding protein encoded by the TFAP2A gene. It is a member of the AP-2 family of transcription factors, which are essential regulators of gene expression during embryonic development, differentiation, and adult tissue homeostasis[2][3][4][6]. AP-2α enhances or represses transcription by binding to specific GC-rich regions in gene promoters and can function as both an activator and a repressor depending on the context[2][4][6]. It forms homo- and heterodimers, interacts with numerous cofactors and regulates genes involved in cell cycle, apoptosis, adhesion, migration, and differentiation[4][6][7]. AP-2α is required for craniofacial development and neural crest cell fate; individuals or animals lacking functional AP-2α show profound developmental defects[2][4]. In tumors, AP-2α can exhibit tumor suppressor functions, notably in melanoma, colon, breast, prostate, and pancreatic cancers[4][6][7][8]. It also acts as a master regulator influencing the expression of other genes integral to cancer progression, making it of therapeutic and biomarker interest, though currently with no direct clinical inhibitors. AP-2α’s regulation of the ERBB2/HER2 oncogene in breast cancer highlights its role as a potential, albeit challenging, therapeutic target[7].

Other names

Activator protein 2 alphaTFAP2AAP2-alphaAP2αActivating enhancer binding protein 2 alpha

Drugs targeting AP-2α-regulated pathways (such as ERBB2/HER2 overexpression) act through modulation of gene transcription or inhibiting pathways upregulated by AP-2α in tumor cells[7]. - Potential for indirect modulation by compounds affecting epigenetic regulation, transcriptional activity, or protein-protein interactions.